Frequency of Triggering Bacteria in Patients with Reactive Arthritis and Undifferentiated Oligoarthritis and the Relative Importance of the Tests Used for Diagnosis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2001 Mar 15

PMID 11247862

Citations 26

Authors

C Fendler

S Laitko

H Sorensen

C Gripenberg-Lerche

A Groh

J Uksila

K Granfors

J Braun

J Sieper

Affiliations

Soon will be listed here.

Abstract

Objective: Reactive arthritis (ReA) triggered by Chlamydia trachomatis or enteric bacteria such as yersinia, salmonella, Campylobacter jejuni, or shigella is an important differential diagnosis in patients presenting with the clinical picture of an undifferentiated oligoarthritis (UOA). This study was undertaken to evaluate the best diagnostic approach.

Patients And Methods: 52 patients with ReA, defined by arthritis and a symptomatic preceding infection of the gut or the urogenital tract, and 74 patients with possible ReA, defined by oligoarthritis without a preceding symptomatic infection and after exclusion of other diagnoses (UOA), were studied. The following diagnostic tests were applied for the identification of the triggering bacterium: for yersinia induced ReA-stool culture, enzyme immunoassay (EIA), and Widal's agglutination test for detection of antibodies to yersinia; for salmonella or campylobacter induced ReA-stool culture, EIA for the detection of antibodies to salmonella and Campylobacter jejuni; for infections with shigella-stool culture; for infections with Chlamydia trachomatis-culture of the urogenital tract, microimmunofluorescence and immunoperoxidase assay for the detection of antibodies to Chlamydia trachomatis.

Results: A causative pathogen was identified in 29/52 (56%) of all patients with ReA. In 17 (52%) of the patients with enteric ReA one of the enteric bacteria was identified: salmonella in 11/33 (33%) and yersinia in 6/33 (18%). Chlamydia trachomatis was the causative pathogen in 12/19 (63%) of the patients with urogenic ReA. In patients with the clinical picture of UOA a specific triggering bacterium was also identified in 35/74 (47%) patients: yersinia in 14/74 (19%), salmonella in 9/74 (12%), and Chlamydia trachomatis in 12/74 (16%).

Conclusions: Chlamydia trachomatis, yersinia, and salmonella can be identified as the causative pathogen in about 50% of patients with probable or possible ReA if the appropriate tests are used.

Citing Articles

Treatment of Reactive Arthritis with Biological Agents.

Agarwal A, Maikap D, Padhan P Curr Rheumatol Rep. 2024; 26(12):450-458.

PMID: 39312088 DOI: 10.1007/s11926-024-01165-6.

Enteric Infection-Associated Reactive Arthritis: A Systematic Review and Meta-Analysis.

Shafiee D, Salpynov Z, Gusmanov A, Khuanbai Y, Mukhatayev Z, Kunz J J Clin Med. 2024; 13(12).

PMID: 38929962 PMC: 11205162. DOI: 10.3390/jcm13123433.

HLA-B27 negative reactive arthritis versus HLA-B27 positive reactive arthritis: A retrospective study.

Ding Y, Xue L Medicine (Baltimore). 2022; 101(35):e30383.

PMID: 36107557 PMC: 9439772. DOI: 10.1097/MD.0000000000030383.

Gut Microbiota-Medication Interaction in Rheumatic Diseases.

Zhang L, Chu C Front Immunol. 2021; 12:796865.

PMID: 34925383 PMC: 8678121. DOI: 10.3389/fimmu.2021.796865.

Reactive arthritis and undifferentiated peripheral spondyloarthritis share human leucocyte antigen B27 subtypes and serum and synovial fluid cytokine profiles.

Parida J, Kumar S, Ahmed S, Chaurasia S, Mukherjee R, Singh R Rheumatology (Oxford). 2021; 60(6):3004-3011.

PMID: 34144605 PMC: 8487659. DOI: 10.1093/rheumatology/keaa746.

References

Pacheco-Tena C, Burgos-Vargas R, Vazquez-Mellado J, Cazarin J . A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol. 1999; 26(6):1338-46. View

Schumacher Jr H, Gerard H, Arayssi T, Pando J, Branigan P, Saaibi D . Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum. 1999; 42(9):1889-93. DOI: 10.1002/1529-0131(199909)42:9<1889::AID-ANR13>3.0.CO;2-W. View

Wilkinson P . Immunoglobulin patterns of antibodies against Brucella in man and animals. J Immunol. 1966; 96(3):457-63. View

Wang S, GRAYSTON J . Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis. 1974; 130(4):388-97. DOI: 10.1093/infdis/130.4.388. View

Granfors K, Viljanen M, TIILIKAINEN A, Toivanen A . Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis. 1980; 141(4):424-9. DOI: 10.1093/infdis/141.4.424. View

Keat A, Thomas B, Taylor-Robinson D, Pegrum G, Maini R, SCOTT J . Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis. 1980; 39(5):431-7. PMC: 1000580. DOI: 10.1136/ard.39.5.431. View

Willkens R, Arnett F, Bitter T, Calin A, Fisher L, FORD D . Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum. 1981; 24(6):844-9. DOI: 10.1002/art.1780240612. View

Kosunen T, Rautelin H, Pitkanen T, Ponka A, Pettersson T . Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients. Infection. 1983; 11(4):189-91. DOI: 10.1007/BF01641193. View

Cevenini R, Sarov I, Rumpianesi F, Donati M, Melega C, Varotti C . Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol. 1984; 37(6):686-91. PMC: 498847. DOI: 10.1136/jcp.37.6.686. View

10.

Granfors K, Toivanen A . ELISA and RIA for serologic diagnosis of yersiniosis. Rev Infect Dis. 1984; 6(3):421-4. DOI: 10.1093/clinids/6.3.421-a. View

11.

Amor B . Reiter's syndrome and reactive arthritis. Clin Rheumatol. 1983; 2(4):315-9. DOI: 10.1007/BF02041549. View

12.

Konttinen Y, Nordstrom D, Bergroth V, Leirisalo-Repo M, Santavirta S . Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed). 1988; 296(6637):1644-5. PMC: 2546171. DOI: 10.1136/bmj.296.6637.1644. View

13.

Inman R, Johnston M, Hodge M, Falk J, Helewa A . Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum. 1988; 31(11):1377-83. DOI: 10.1002/art.1780311106. View

14.

Isomaki O, Vuento R, Granfors K . Serological diagnosis of salmonella infections by enzyme immunoassay. Lancet. 1989; 1(8652):1411-4. DOI: 10.1016/s0140-6736(89)90124-4. View

15.

Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H . Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991; 34(1):6-14. DOI: 10.1002/art.1780340103. View

16.

Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A . The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991; 34(10):1218-27. DOI: 10.1002/art.1780341003. View

17.

Maki-Ikola O, Leirisalo-Repo M, Kantele A, TOIVANEN P, Granfors K . Salmonella-specific antibodies in reactive arthritis. J Infect Dis. 1991; 164(6):1141-8. DOI: 10.1093/infdis/164.6.1141. View

18.

Khan M . An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum Dis Clin North Am. 1992; 18(1):1-10. View

19.

Maki-Ikola O, Granfors K . Salmonella-triggered reactive arthritis. Lancet. 1992; 339(8801):1096-8. DOI: 10.1016/0140-6736(92)90675-s. View

20.

Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S . Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol. 1992; 19(8):1236-42. View